Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Book
|
![]() |
Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. BaumISBN: 9783031335327 ;ISBN: 3031335333 ;ISBN: 9783031335334 ;ISBN: 3031335325 ;DOI: 10.1007/978-3-031-33533-4Digital Resources/Online E-Resources |
2 |
Material Type: Article
|
![]() |
Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude ReubiEuropean journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.741-743 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2020). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04679-0 ;PMID: 32020369Full text available |
3 |
Material Type: Article
|
![]() |
Editorial: Response assessment of radioligand therapiesFrontiers in oncology, 2022-07, Vol.12, p.904337-904337 [Peer Reviewed Journal]Copyright © 2022 Lopci and Prasad 2022 Lopci and Prasad ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2022.904337 ;PMID: 35965585Full text available |
4 |
Material Type: Article
|
![]() |
Controller design and multi-objective optimization of heavy goods vehicle suspension system by geometry-inspired GAStructural and multidisciplinary optimization, 2021-07, Vol.64 (1), p.89-111 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 ;The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. ;ISSN: 1615-147X ;EISSN: 1615-1488 ;DOI: 10.1007/s00158-021-02860-zFull text available |
5 |
Material Type: Article
|
![]() |
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATEEuropean journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.881-894 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-019-04439-9 ;PMID: 31414209Full text available |
6 |
Material Type: Article
|
![]() |
Nephrotoxicity after radionuclide therapiesTranslational oncology, 2022-01, Vol.15 (1), p.101295-101295, Article 101295 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Inc. ;2021 Published by Elsevier Inc. 2021 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2021.101295 ;PMID: 34847420Full text available |
7 |
Material Type: Article
|
![]() |
Editorial: Bridging the gap to molecular imaging and theranosticsFrontiers in nuclear medicine, 2024-04, Vol.4 [Peer Reviewed Journal]EISSN: 2673-8880 ;DOI: 10.3389/fnume.2024.1385097Full text available |
8 |
Material Type: Article
|
![]() |
Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imagingWorld journal of urology, 2022-02, Vol.40 (2), p.307-315 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0724-4983 ;EISSN: 1433-8726 ;DOI: 10.1007/s00345-021-03856-6 ;PMID: 34779884Full text available |
9 |
Material Type: Article
|
![]() |
mTOR Inhibitors as Radiosensitizers in Neuroendocrine NeoplasmsFrontiers in oncology, 2021-02, Vol.10, p.578380-578380 [Peer Reviewed Journal]Copyright © 2021 Exner, Arrey, Prasad and Grötzinger. ;COPYRIGHT 2021 Frontiers Research Foundation ;Copyright © 2021 Exner, Arrey, Prasad and Grötzinger 2021 Exner, Arrey, Prasad and Grötzinger ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2020.578380 ;PMID: 33628728Full text available |
10 |
Material Type: Article
|
![]() |
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practiceEuropean journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2358-2371 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04712-2 ;PMID: 32062681Full text available |
11 |
Material Type: Article
|
![]() |
Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomyEuropean journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2339-2347 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04718-w ;PMID: 32157427Full text available |
12 |
Material Type: Article
|
![]() |
Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMAFrontiers in oncology, 2022-12, Vol.12, p.1066926-1066926 [Peer Reviewed Journal]Copyright © 2022 Assadi, Manafi-Farid, Jafari, Keshavarz, Divband, Moradi, Adinehpour, Samimi, Dadgar, Jokar, Mayer and Prasad 2022 Assadi, Manafi-Farid, Jafari, Keshavarz, Divband, Moradi, Adinehpour, Samimi, Dadgar, Jokar, Mayer and Prasad ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2022.1066926Full text available |
13 |
Material Type: Article
|
![]() |
A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in MicePharmaceutics, 2021-12, Vol.13 (12), p.2132 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1999-4923 ;EISSN: 1999-4923 ;DOI: 10.3390/pharmaceutics13122132 ;PMID: 34959413Full text available |
14 |
Material Type: Article
|
![]() |
Optimization of Radiolabeling of a [ 90 Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell TransplantationCancers, 2023-07, Vol.15 (14), p.3660 [Peer Reviewed Journal]2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15143660 ;PMID: 37509321Full text available |
15 |
Material Type: Article
|
![]() |
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate CancerCancers, 2021-07, Vol.13 (14), p.3607 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13143607 ;PMID: 34298822Full text available |
16 |
Material Type: Article
|
![]() |
Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer CentreCancers, 2023-06, Vol.15 (12), p.3216 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15123216 ;PMID: 37370826Full text available |
17 |
Material Type: Article
|
![]() |
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225EJNMMI research, 2022-10, Vol.12 (1), p.65-11, Article 65 [Peer Reviewed Journal]The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2191-219X ;EISSN: 2191-219X ;DOI: 10.1186/s13550-022-00935-6 ;PMID: 36182983Full text available |
18 |
Material Type: Article
|
![]() |
Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell CarcinomaPharmaceutics, 2022-07, Vol.14 (7), p.1466 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1999-4923 ;EISSN: 1999-4923 ;DOI: 10.3390/pharmaceutics14071466 ;PMID: 35890361Full text available |
19 |
Material Type: Article
|
![]() |
Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRTPharmaceutics, 2022-06, Vol.14 (6), p.1278 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1999-4923 ;EISSN: 1999-4923 ;DOI: 10.3390/pharmaceutics14061278 ;PMID: 35745849Full text available |
20 |
Material Type: Article
|
![]() |
In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2nd Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With 177Lu-PSMAFrontiers in oncology, 2021-03, Vol.11, p.578093-578093 [Peer Reviewed Journal]Copyright © 2021 Prasad, Huang, Prasad, Makowski, Czech and Brenner 2021 Prasad, Huang, Prasad, Makowski, Czech and Brenner ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2021.578093 ;PMID: 33816225Full text available |